Mahadevia Ankit

CIK 00017209741 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001720974

Recent Transactions

50 trades

Sale
Spero Therapeutics, Inc.$SPRO
Common Stock
2025-08-28$1.97/sh−6,572→ 703,294 total
Award
Spero Therapeutics, Inc.$SPRO
Common Stock
2025-06-12+20,000→ 709,866 total
Sale
Spero Therapeutics, Inc.$SPRO
Common Stock
2025-02-05$0.78/sh−13,959→ 745,126 total
Sale
Spero Therapeutics, Inc.$SPRO
Common Stock
2025-02-05$0.78/sh−55,260→ 689,866 total
Sale
Spero Therapeutics, Inc.$SPRO
Common Stock
2024-08-27$1.35/sh−5,912→ 759,085 total
Award
Spero Therapeutics, Inc.$SPRO
Common Stock
2024-05-29+20,000→ 764,997 total
Sale
Spero Therapeutics, Inc.$SPRO
Common Stock
2024-02-02$1.37/sh−63,795→ 744,997 total
Award
Spero Therapeutics, Inc.$SPRO
Common Stock
2023-10-05+20,000→ 808,792 total
Sale
Spero Therapeutics, Inc.$SPRO
Common Stock
2023-08-28$1.26/sh−9,040→ 788,792 total
Sale
Spero Therapeutics, Inc.$SPRO
Common Stock
2023-02-03$1.81/sh−12,286→ 797,832 total
Award
Spero Therapeutics, Inc.$SPRO
Common Stock
2023-02-01+531,914→ 810,118 total
Award
Spero Therapeutics, Inc.$SPRO
Common Stock
2022-02-01+134,168→ 278,204 total
Award
Spero Therapeutics, Inc.$SPRO
Stock Option (Right to Buy)
2022-02-01+187,730→ 187,730 total
Sale
Spero Therapeutics, Inc.$SPRO
Common Stock
2021-12-27$14.58/sh−8,000→ 144,036 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Common Stock
2021-12-27$5.90/sh+8,000→ 152,036 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Stock Option (Right to Buy)
2021-12-27−8,000→ 486,809 total
Award
Spero Therapeutics, Inc.$SPRO
Common Stock
2021-08-26+78,219→ 144,036 total
Award
Spero Therapeutics, Inc.$SPRO
Stock Option (Right to Buy)
2021-02-01+179,319→ 179,319 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Stock Option (Right to Buy)
2020-11-04−7,370→ 494,809 total
Sale
Spero Therapeutics, Inc.$SPRO
Common Stock
2020-11-04$14.43/sh−7,370→ 65,817 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Common Stock
2020-11-04$5.90/sh+7,370→ 73,187 total
Sale
Spero Therapeutics, Inc.$SPRO
Common Stock
2020-11-03$14.27/sh−2,137→ 65,817 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Common Stock
2020-11-03$5.90/sh+2,137→ 67,954 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Stock Option (Right to Buy)
2020-11-03−2,137→ 502,179 total
Sale
Spero Therapeutics, Inc.$SPRO
Common Stock
2020-10-23$14.25/sh−20→ 65,817 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Common Stock
2020-10-23$5.90/sh+20→ 65,837 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Stock Option (Right to Buy)
2020-10-23−20→ 504,316 total
Sale
Spero Therapeutics, Inc.$SPRO
Common Stock
2020-10-14$14.25/sh−105→ 65,817 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Common Stock
2020-10-14$5.90/sh+105→ 65,922 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Stock Option (Right to Buy)
2020-10-14−105→ 504,336 total
Sale
Spero Therapeutics, Inc.$SPRO
Common Stock
2020-10-13$14.28/sh−14,367→ 65,817 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Common Stock
2020-10-13$5.90/sh+14,367→ 80,184 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Stock Option (Right to Buy)
2020-10-13−14,367→ 504,441 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Common Stock
2020-09-08$5.90/sh+774→ 66,591 total
Sale
Spero Therapeutics, Inc.$SPRO
Common Stock
2020-09-08$14.25/sh−774→ 65,817 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Stock Option (Right to Buy)
2020-09-08−774→ 518,808 total
Sale
Spero Therapeutics, Inc.$SPRO
Common Stock
2020-07-09$14.31/sh−2,293→ 65,817 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Common Stock
2020-07-09$5.90/sh+2,293→ 68,110 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Stock Option (Right to Buy)
2020-07-09−2,293→ 519,582 total
Sale
Spero Therapeutics, Inc.$SPRO
Common Stock
2020-07-07$14.25/sh−754→ 65,817 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Stock Option (Right to Buy)
2020-07-07−754→ 521,875 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Common Stock
2020-07-07$5.90/sh+754→ 66,571 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Stock Option (Right to Buy)
2020-06-25−2,642→ 522,629 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Common Stock
2020-06-25$5.90/sh+2,642→ 68,459 total
Sale
Spero Therapeutics, Inc.$SPRO
Common Stock
2020-06-25$14.25/sh−2,642→ 65,817 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Common Stock
2020-06-24$5.90/sh+3,880→ 69,697 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Stock Option (Right to Buy)
2020-06-24−3,880→ 525,271 total
Sale
Spero Therapeutics, Inc.$SPRO
Common Stock
2020-06-24$14.28/sh−3,880→ 65,817 total
Sale
Spero Therapeutics, Inc.$SPRO
Common Stock
2020-06-23$14.33/sh−8,045→ 65,817 total
Exercise/Conversion
Spero Therapeutics, Inc.$SPRO
Stock Option (Right to Buy)
2020-06-23−8,045→ 529,151 total

Companies

Spero Therapeutics, Inc.
Director
$SPRO

Recent Filings

Address

C/O SPERO THERAPEUTICS, INC. 675 MASSACHUSETTS AVENUE, 14TH FLOOR

CAMBRIDGE, MA, 02139

View on SEC.gov